Evidence map›Paper›PMID 39355020›Full record

ArticleFrontiers in nuclear medicine2023

Non-invasive in vivo imaging of porcine islet xenografts in a preclinical model with [

Felix Lindheimer, Magdalena Julia Lindner, Rosel Oos, Mohsen Honarpisheh, Yichen Zhang, Yutian Lei, Lelia Wolf-van Buerck, Franz Josef Gildehaus, Simon Lindner, Peter Bartenstein and 4 more

Abstract read
In one paragraph

Article in Frontiers in nuclear medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Felix Lindheimer *Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.
Magdalena Julia Lindner *Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.
Rosel OosDepartment of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.
Mohsen HonarpishehMedizinische Klinik und Poliklinik IV, Diabetes Center, University Hospital of Munich, LMU Munich, Munich, Germany.
Yichen ZhangMedizinische Klinik und Poliklinik IV, Diabetes Center, University Hospital of Munich, LMU Munich, Munich, Germany.
Yutian LeiMedizinische Klinik und Poliklinik IV, Diabetes Center, University Hospital of Munich, LMU Munich, Munich, Germany.
Lelia Wolf-van BuerckMedizinische Klinik und Poliklinik IV, Diabetes Center, University Hospital of Munich, LMU Munich, Munich, Germany.
Franz Josef GildehausDepartment of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.
Simon LindnerDepartment of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.
Peter BartensteinDepartment of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.
Elisabeth KemterChair for Molecular Animal Breeding and Biotechnology, Gene Center and Department of Veterinary Sciences, LMU Munich, Munich, Germany.
Eckhard WolfChair for Molecular Animal Breeding and Biotechnology, Gene Center and Department of Veterinary Sciences, LMU Munich, Munich, Germany.
Jochen SeisslerMedizinische Klinik und Poliklinik IV, Diabetes Center, University Hospital of Munich, LMU Munich, Munich, Germany.
Sibylle ZieglerDepartment of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Islet xenotransplantation may be a therapeutic option in type 1 diabetes. Recent advances in generating genetically modified source pigs offer advantages as immune suppressants can potentially be eliminated after the transplantation. Therapy monitoring would greatly benefit from noninvasive methods for assessing the viability of transplanted islets. Peptide-based positron emission tomography (PET) targeting the glucagon-like peptide-1 receptor (GLP1R) expression on beta cells may offer a procedure that can directly be translated from an experimental setting to the clinic. The aim of this study was to establish the labeling of the GLP1R ligand [ Materials and methods: Mice with engrafted neonatal porcine islet cell clusters (NPICCs) under the kidney capsule, into the inguinal fold, or the lower hindlimb muscle were studied. After reaching normoglycemia, the mice were injected with [ Results: NPICCs in the lower right hindlimb muscle could be detected Discussion: PET with [

Indexed as

autoradiographyexendin-4PETtransplantationxenografts

Identifiers

PMID39355020
PMCPMC11440980

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.